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The traditional approach to protect healthcare workers
(HCWs) from acquiring infections in the hospital setting has been based on isolating patients suspected of
having an infection, until the infection is ruled out (e.g.
tuberculosis). This approach has been used as a way
to protect HCWs from COVID-19. Patients suspected
of having COVID-19 are placed in contact and airborne
isolation until the infection is ruled out.
As the worldwide number of nurses and physician
developing COVID-19 increases, and the number of
deaths among nurses and physicians continue to
growth, it is very clear that our traditional approach
has drastically failed to protect HCWs. Among the
several reasons for this failure is the fact that patients
with COVID-19 may arrive to the hospital with atypical presentations (e.g. diarrhea), and as we keep learning about COVID-19 we continue to find new ways that
this disease may initially present (e.g. anosmia). Our
traditional approach to isolate only suspected patients
is failing primarily because we are failing to suspect the
disease in patients with non-classical clinical presentations.
At the University of Louisville, we started a COVID19 surveillance program in all ten hospitals in the
city.[1] We are currently testing patients admitted to the
Louisville hospitals with signs and symptoms of respiratory infection or gastrointestinal infection. We have
tested 2,900 patients with 342 positive tests. We now
suggest that universal test-and-isolate for all hospitalized patients should be our new approach to protect
HCWs. An algorithm to implement this new approach
is depicted in Figure 1.
According to this approach, at the time of hospital admission all patients will have a nasopharyngeal swab
performed for SARS-CoV-2 identification by reverseULJRI | https://ir.library.louisville.edu/jri/vol4/iss1/6

transcriptase polymerase-chain-reaction (RT-PCR). If
the patient has no risk factors for COVID-19, the patient
will be placed in contact and droplet isolation. If the patient has risk factors for COVID-19, the patient will be
placed in contact and airborne isolation. According to
the number and types of risk factors, patients should be
classified as being low risk versus high risk for COVID19. We suggest that a local COVID-19 multidisciplinary
clinical team perform stratification of patients as being
a) No Risk, b) Low Risk, and c) High Risk. There are no
established criteria to define a patient as high risk, but
a patient hospitalized with pneumonia with a characteristic computed tomography (CT) showing bilateral
ground-glass opacities should always be considered a
high risk patient.
Patients with no risk factors who test negative for
COVID-19 can be removed from isolation. On the other
hand, in patients with risk factors for COVID-19, a
nasopharyngeal swab with a negative PCR for SARSCoV-2 should not be used as the single criteria to discontinue isolation. The determination to discontinue
isolation should be based on whether the patient has
been stratified into the high-risk group versus the low
risk group. If the patient is low risk and tests negative, isolation may be discontinued. If the patient is at
high risk for COVID-19 and a nasopharyngeal swab is
negative for SARS-CoV-2 the patient should remain in
contact and airborne isolation. We have witnessed two
patients with classical CT findings with negative nasopharyngeal swab RT-PCR, but positive RT-PCR for
SARS-CoV-2 in sputum samples.
In addition to universal test-and-isolation all patients
at time of hospitalization, we suggest that all patients
who develop cough, shortness of breath, hypoxemia,
or pneumonia during hospitalization be retested. Since
COVID-19 may have an incubation period of several
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Figure 1. Suggested algorithm to implement universal test-and-isolate for all hospitalized patients.

days or weeks, any patient who develops pneumonia
during hospitalization should be tested for COVID-19.
We have witnessed a patient who developed pneumonia seven days after hospital admission, with classical
CT scan finding for COVID-19 and a positive nasopharyngeal swab RT-PCR for SARS-CoV-2.

In conclusion, we believe that the implementation of
a universal test-and-isolate for all newly admitted patients might be a critical measure to help prevent
COVID-19 in nurses, physicians, and other HCWs.
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